BB Biotech AG announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced net loss was CHF 381.766 million compared to net income of CHF 241.865 million a year ago. Basic loss per share was CHF 6.89 compared to basic earnings per share of CHF 4.37 a year ago. For the nine months, net income was CHF 172.210 million compared to CHF 171.510 million a year ago. Basic earnings per share was CHF 3.11 compared to CHF 3.1 a year ago.